CTK OnSite COVID-19 & Influenza A/B Ag Rapid Test

COVID-19 + Influenza A/B Ag Rapid Test CE

The OnSite COVID-19 + Influenza A/B Ag Rapid Test is a lateral flow immunoassay for the simultaneous qualitative detection and differentiation of SAR-CoV2, Influenza A, and/or Influenza B viral antigens directly from anterior nasal or nasopharyngeal swab specimens, within the first seven days of symptom onset. The test is intended for use by healthcare professionals or personnel train in rapid test procedure.

PRODUCT FEATURES

Convenient

• Differentiates 3 infections in 1 test.

• Efficiently tests for 3 infections with only 1 patient sample.

• Pre-filled extraction tubes simplify test procedure.

• Results in 15 minutes.

Reliable Results

• Accurate detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B infection within the first seven days of symptom onset.

• Detects circulating SARS-CoV-2 Variants and the CDC’s recommended Influenza strains from 2019-2022.

• No cross-reactivity with other respiratory viruses.